Covered recipient · General Payments record
PETER G HASAPIS
Allopathic & Osteopathic Physicians Internal Medicine
General Payments · PY2018–2024
$1,625.09
- Reported across 82 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2024 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $374.54 | 17 |
By paying entity
PY2024 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| Exact Sciences Corporation | $85.79 | 3 |
| Merck Sharp & Dohme Corporation | $47.22 | 2 |
| Novo Nordisk AS | $46.18 | 2 |
| Kaleo, Inc. | $41.82 | 2 |
| Corcept Therapeutics | $23.91 | 1 |
| Lilly USA, LLC | $23.87 | 1 |
| Amgen Inc. | $19.77 | 1 |
| ABBVIE INC. | $19.68 | 1 |
| E.R. Squibb & Sons, L.L.C. | $19.30 | 1 |
| PFIZER INC. | $17.52 | 1 |
| Acerta Pharma LLC | $15.33 | 1 |
| Tris Pharma Inc | $14.15 | 1 |
By program year
All program years on this page · sorted by year
Payment records · PY2024 (17)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| ABBVIE INC. | $19.68 | 07/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1103888749 | CMS |
| Amgen Inc. | $19.77 | 05/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117574542 | CMS |
| AstraZeneca Pharmaceuticals LP | $15.33 | 10/24/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1105677633 | CMS |
| Corcept Therapeutics | $23.91 | 06/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1117730256 | CMS |
| E.R. Squibb & Sons, L.L.C. | $19.30 | 12/02/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1101257109 | CMS |
| Exact Sciences Corporation | $21.47 | 04/03/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114695162 | CMS |
| Exact Sciences Corporation | $29.66 | 06/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114695168 | CMS |
| Exact Sciences Corporation | $34.66 | 12/19/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1114695174 | CMS |
| kaleo, Inc. | $17.13 | 02/07/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126628996 | CMS |
| kaleo, Inc. | $24.69 | 05/29/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1126628998 | CMS |
| Lilly USA, LLC | $23.87 | 05/22/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1135316903 | CMS |
| Merck Sharp & Dohme LLC | $22.91 | 08/14/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141679157 | CMS |
| Merck Sharp & Dohme LLC | $24.31 | 10/30/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1141864241 | CMS |
| Novo Nordisk Inc | $21.33 | 03/20/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1096704213 | CMS |
| Novo Nordisk Inc | $24.85 | 09/05/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1097831332 | CMS |
| PFIZER INC. | $17.52 | 05/15/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1131441329 | CMS |
| Tris Pharma Inc | $14.15 | 04/17/2024 | Food and Beverage | Undisputed | 01/23/2026 | 1147230595 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018, 2019, 2020, 2023, 2024
- Generated from
- OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.